Bloomberg Features P5 and its Efforts to Improve on RV144 Results

Bloomberg ran a piece on the Pox-Protein Public Private Partnership (P5) and their plans to improve on the RV144 Thai HIV vaccine trial results. Check it out,

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account